View, Inc.
VIEW News Today: Stay Updated with the Latest View, Inc. News in Real Time
Find VIEW news now at Meyka AI. Stay informed with the latest View, Inc. stocks updates, including price news, market analysis, and expert insights.

Tech Earnings: Alphabet, Amazon Beat Meta in AI Race During Earnings Season
The latest Tech Earnings season has made one thing clear. Artificial Intelligence (AI) is now the main battleground for Big Tech. Companies are no longer competing only on revenue or users. They are competing on AI power. In this earnings cycle, Alphabet and Amazon clearly moved ahead. Meanwhile, Meta Platforms delivered strong results but failed…

SPOT Stock April 30: Spotify Earnings Miss Triggers 14% Plunge
SPOT stock plunges 14% on April 30 after Q1 earnings miss. Wall Street cuts price targets. Subscriber growth concerns weigh on Spotify’s outlook.

BNP Paribas Q1 Profit Hits €3.22B Record Driven by Trading and AXA IM Integration
BNP Paribas reported a record €3.22 billion profit for the first quarter of 2026, highlighting the strength of Europe’s banking sector during volatile markets. The results, announced on April 30, 2026, were fueled by strong trading performance and the integration of AXA Investment Managers. Revenue also climbed above analyst forecasts, showing the bank’s growing focus…

WT WisdomTree Earnings Preview: May 1, 2026
WisdomTree earnings preview for May 1, 2026. Analysts expect $0.24 EPS and $156M revenue. Historical performance shows mixed results.

CNK Cinemark Holdings Earnings Preview May 1, 2026
Cinemark (CNK) reports Q1 2026 earnings May 1. Analysts expect -$0.07 EPS, $632.74M revenue. Stock at $29.01.

TEX Earnings Preview: Terex Reports May 1, EPS Estimate $0.78
Terex (TEX) earnings preview for May 1, 2026. Analysts expect $0.78 EPS and $1.70B revenue. Historical performance analysis and key metrics.

GGII Stock Surges 9900% in April 2026 on Pink Sheets
GGII stock exploded 9900% to $0.0001 on April 30, 2026, with 945K volume. Green Globe International trades on PNK.

AMRX Earnings Preview: Amneal Pharmaceuticals Q1 2026 May 1
Amneal Pharmaceuticals (AMRX) reports Q1 2026 earnings May 1. Analysts expect $0.1691 EPS and $719.66M revenue. What to watch.

AMRX Earnings Preview: May 1 Report, $0.17 EPS Expected
Amneal Pharmaceuticals earnings preview for May 1, 2026. Analysts expect $0.1691 EPS and $719.66M revenue. Historical performance analysis inside.